Newsbenzinga
Kura Oncology Highlights New Clinical And Translational Data Supporting Darlifarnib As Potential Foundational Combination Platform For KRAS-Mutant Cancers And Other Targeted Therapy Settings
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…